• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.

作者信息

Fourati S, Pawlotsky J-M

机构信息

Department of Virology, National Reference Center for Viral Hepatitis B, C and Delta, Hôpital Henri Mondor, Université Paris- Est, INSERM U955, Créteil, France.

出版信息

Aliment Pharmacol Ther. 2018 Mar;47(6):849-850. doi: 10.1111/apt.14520.

DOI:10.1111/apt.14520
PMID:29446133
Abstract
摘要

相似文献

1
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.社论：对于接受无干扰素直接作用抗病毒联合治疗的丙型肝炎患者，预测持续病毒学应答是否需要额外检测？作者回复。
Aliment Pharmacol Ther. 2018 Mar;47(6):849-850. doi: 10.1111/apt.14520.
2
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?
Aliment Pharmacol Ther. 2018 Mar;47(6):848-849. doi: 10.1111/apt.14508.
3
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply.社论：无干扰素直接作用抗病毒药物对丙型肝炎和冷球蛋白血症患者是一大福音——作者回复。
Aliment Pharmacol Ther. 2018 Oct;48(7):772-773. doi: 10.1111/apt.14936.
4
Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy.直接抗病毒治疗后持续病毒学应答48周以上的丙型肝炎“真正”晚期复发
J Hepatol. 2017 Apr;66(4):862-863. doi: 10.1016/j.jhep.2017.01.002. Epub 2017 Jan 9.
5
Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply.
Aliment Pharmacol Ther. 2019 Jan;49(1):117-118. doi: 10.1111/apt.15065.
6
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.社论：丙型肝炎直接抗病毒药物与肾脏——作者回复
Aliment Pharmacol Ther. 2017 Aug;46(3):379-380. doi: 10.1111/apt.14187.
7
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.终末期肾病患者使用丙型肝炎病毒直接抗病毒药物的“真实世界”经验。
Int J Artif Organs. 2018 Jul;41(7):363-370. doi: 10.1177/0391398818763478. Epub 2018 Mar 27.
8
New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy
.接受直接抗病毒治疗获得持续病毒学应答后新发丙型肝炎病毒相关性肾小球肾炎
Clin Nephrol. 2017 May;87 (2017)(5):261-266. doi: 10.5414/CN109019.
9
Hepatitis C reinfection in prisons with broad access to Direct Acting Antiviral treatments.在广泛可获得直接抗病毒治疗的监狱中丙型肝炎再感染情况。
Int J Drug Policy. 2020 Mar;77:102597. doi: 10.1016/j.drugpo.2019.11.005. Epub 2020 Jan 15.
10
Hepatitis C virus genotype 4: Genotype 1's little brother.
J Viral Hepat. 2017 Jan;24(1):4-12. doi: 10.1111/jvh.12620. Epub 2016 Dec 1.